Illumina Reshapes Board with Three Retirements and One New Nomination

By Chris Stiles • Thursday, April 02 10:10 • Permanent Link

Illumina is reshaping its board with three retirements and one new nomination ahead of its annual meeting.

Frances Arnold, Robert S. Epstein, and Gary S. Guthart will step down from the board. In their place, the company has nominated David P. King, the former executive chairman and CEO of Laboratory Corporation of America Holdings, for election.

King’s background is heavily weighted toward healthcare and life sciences. He has served on the boards of Privia Health, AmSurg, Smith & Nephew, ZimVie, VaxCare, and Health Channels. Before LabCorp, he was a partner at Hogan & Hartson, where he worked on healthcare fraud and abuse matters.

The board change follows a period Illumina described as transformation, with chair Scott Gottlieb saying the company is focused on the next phase of growth and innovation. As a result of these announcements, the company's shares have moved -1.43% on the market, and are now trading at a price of $124.40. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.